240+ leading individuals in healthcare, life sciences and private equity gathered at The Langham Hotel in central London for HPE Europe 2023 for a day packed with fireside chats, in-depth plenary sessions and an abundance of...more
Welcome to the inaugural Private Markets Update, which highlights developments in the European private markets, covering the issues that matter to investors in alternative assets. Touching on themes as diverse as predictions...more
5/31/2023
/ Acquisitions ,
Capital Markets ,
Cross-Border ,
EU ,
FinTech ,
Germany ,
Investment ,
Investors ,
Mergers ,
National Security ,
OECD ,
Pillar 2 ,
Private Equity ,
Private Equity Funds ,
Restructuring ,
UK
After an insightful conference in Cannes, our partners have compiled some of the key takeaways from IPEM 2022.
As well as exploring the private equity landscape in the UK, Germany, France and Italy, we also explore the...more
10/25/2022
/ Acquisitions ,
Debt ,
Economic Growth ,
Environmental Social & Governance (ESG) ,
EU ,
France ,
Funding ,
Germany ,
Healthcare ,
Investment ,
Investors ,
Italy ,
Mergers ,
Private Equity ,
Publicly-Traded Companies ,
Small and Medium-Sized Enterprises (SMEs) ,
UK ,
Venture Capital
This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions.
We will be joined by investors including key players...more
6/9/2021
/ Acquisitions ,
Business Valuations ,
Coronavirus/COVID-19 ,
Financing ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Lenders ,
Leveraged Loans ,
Life Sciences ,
Mergers ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Management ,
Webinars
In a climate where there are so many unknown factors challenging valuation methodologies, we explore a number of mechanisms that European dealmakers may consider during the Coronavirus (COVID-19) pandemic in order to bridge...more
12/4/2020
/ Acquisitions ,
Buyers ,
Coronavirus/COVID-19 ,
Deferred Consideration ,
Earn-Outs ,
EBITDA ,
EU ,
Fairness Standard ,
Fixed Price Contracts ,
Global Dealmaking ,
Indemnity Insurance ,
Mergers ,
Sellers ,
Warranty Insurance
The challenges raised by the Coronavirus (COVID-19) crisis initially led to a dramatic fall in share prices and market uncertainty. Although the capital markets have largely recovered their value since the initial COVID-19...more
The requirement to stay at home is giving many of us the opportunity to undertake (or no excuse to ignore) the household and DIY tasks at home that have long been at the bottom of the to-do list. Similarly, directors,...more
Following the wider outbreak of the coronavirus (COVID-19) around the world, radical—and sometimes controversial—actions have been and are further expected to be taken by national, federal and local governments and...more
3/16/2020
/ Acquisitions ,
Business Interruption ,
Capital Markets ,
Commercial Insurance Policies ,
Contract Terms ,
Coronavirus/COVID-19 ,
Corporate Financing ,
Corporate Governance ,
Crisis Management ,
Debt Restructuring ,
Emergency Management Plans ,
Employer Responsibilities ,
Health Insurance ,
Healthcare Facilities ,
Life Sciences ,
Mergers ,
Portfolio Companies ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Regulatory Standards ,
Risk Assessment ,
Risk Mitigation ,
Supply Chain